Research & Innovation International Rare Disease Consortium: Data Sharing Policy 3 rd International Traumatic Brain Injury Research Meeting Catherine BERENS.

Slides:



Advertisements
Similar presentations
Research & Innovation Towards better access to scientific information "Strategy, policy and funding" Copenhagen June 13 th Octavi Quintana Trias Director,
Advertisements

DG Enterprise and Industry Approach on Combating Counterfeit Medicines Council of Europe Conference “Europe against Counterfeit Medicines” Session: Key.
Interest Group Climate & Adaptation within the network of European EPAs Jelle van Minnen Netherlands Environmental Assessment Agency (PBL)
European Innovation for Active and Healthy Ageing
Research & Innovation Evolution from IMI1 to IMI2: challenges ahead Elmar Nimmesgern, PhD DG Research & Innovation 1.
The Paediatric Regulation
EFSA’s Mission and Priorities Bernhard Berger Head of the Advisory Forum and Scientific Cooperation Unit Conference “Importance of food additives today.
Clinical trials in Europe Emma Greenwood, Policy Manager Thursday 23 rd February.
Update on a recently launched European R&D endeavour: The Innovative Medicines Initiative (IMI) FERS meeting Brussels, 7 th April 2008.
ESTABLISHING A CO-OPERATIVE FRAMEWORK BETWEEN THE ACCREDITATION COUNCIL OF TRINIDAD AND TOBAGO (ACTT) AND PROFESSIONAL STATUTORY AND REGULATORY BODIES.
Research European Commission Life Sciences and Biotechnology A Strategy for Europe Christian Patermann.
22 Feb 2007EU-Russia Co-operation1 Dr. Stephan Pascall Advisor to the Director Directorate G: Components and Systems DG Information Society and Media European.
EUROPEAN REGIONAL DEVELOPMENT FUND Event – date, place About INTERREG EUROPE INTERREG EUROPE INTERREG IVC Joint Technical Secretariat Iruma Kravale, The.
The Italian Institutional Design for Administrative Simplification HIGH LEVEL REGIONAL SEMINAR ON “STRATEGIES, TOOLS AND CAPACITIES FOR ADMINISTRATIVE.
Research and Innovation Research and Innovation Research and Innovation Research and Innovation Research Infrastructures and Horizon 2020 The EU Framework.
An introduction to the EU and its legislation. Member States currently 15 –Austria- Ireland –Belgium- Luxembourg –Denmark- Netherlands –Finland- Portugal.
The PROGRESS program Luk Zelderloo EASPD Project Development Workshop Sofia, Bulgaria.
Critical Role of ICT in Parliament Fulfill legislative, oversight, and representative responsibilities Achieve the goals of transparency, openness, accessibility,
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
The Role of Patients in EU Policy Development European Health Forum Gastein October 2003 – Bad Gastein Presented by Erick Savoye Director of the European.
Working Group on Crime Statistics 9 June 2011 Point 3. Commission Activities ( Doc. CR/WG2011/1)
Terezia Sinkova EFSA The new EU Food Safety Agency.
6 April Research for a secure Europe Christiane BERNARD European Commission - DG Enterprise and Industry Athens.
Towards a European network for digital preservation Ideas for a proposal Mariella Guercio, University of Urbino.
A major step towards a Europe for Health Directive on patients’ rights in cross-border healthcare DG SANCO D2 Healthcare Systems.
European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS
Europe's work in progress: quality of mHealth Pēteris Zilgalvis, J.D., Head of Unit, Health and Well-Being, DG CONNECT Voka Health Community 29 September.
EU Funding opportunities : Rights, Equality and Citizenship Programme Justice Programme Jose Ortega European Commission DG Justice.
1 DG Enterprise & Industry European Commission Conference on Better Regulation: Practical Steps Forward Reykjavík 6 June 2006 OVERVIEW OF THE BETTER REGULATION.
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
European Standards on Confidentiality and Privacy in Healthcare Dr Colin M Harper Division of Psychiatry & Neuroscience Queen’s University.
DETERMINE Working document # 4 'Economic arguments for addressing social determinants of health inequalities' December 2009 Owen Metcalfe & Teresa Lavin.
1/14 White Paper, “A Strategy for Europe on Nutrition, Overweight and Obesity related Health Issues” Platform Plenary 4 July 2007 Ceri Thompson Directorate-General.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
European Commission Directorate-General for Employment, Social Affairs and Equal Opportunities ─ Unit Social and Demographic Analysis 1 Active.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENSHIP RIGHT AND CITIZENSHIP
EARIP Stakeholder Workshop Models and healthcare systems: transferability of best practice across Europe Dr. Aurélien PEREZ European Commission Health.
Research and Innovation Charter & Code, the Human Resources Strategy for Researchers and related EU policy initiatives Dr. Dagmar Meyer European Commission.
European Aviation Safety Agency Head of Aircraft Product Certification
China July 2004 The European Union Programmes for EU-China Cooperation in ICT.
19-20 October 2010 IT Directors’ Group meeting 1 Item 6 of the agenda ISA programme Pascal JACQUES Unit B2 - Methodology/Research Local Informatics Security.
EU Cybersecurity Strategy and Proposal for Directive on network and information security (NIS) {JOIN(2013) 1 final} {COM(2013) 48 final} Digital Enlightenment.
SEVESO II transposition and implementation: Possible approaches and lessons learned from member states and new member states SEVESO II transposition and.
Dealing with Brussels ! Peter M. Swift Managing Director, INTERTANKO.
Research and Innovation Research and Innovation Promoting health research and innovation in Horizon 2020 Research and Innovation Research and Innovation.
National Information Day Greece 23 July 2015 Funding priorities under the work plan 2015.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
EU context (networks & initiatives) and expectations EU context (networks & initiatives) and expectations Michel Viaud and/or Ingrid Weiss EPIA, Brussels,
Richard Escritt, Director – Coordination of Community Actions DG Research, European Commission “The development of the ERA: Experiences from FP6 and reflections.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
The EU & DG Enterprise & Industry / 1 Steve Rogers, Győr, 16 January 2007 The European Union and DG Enterprise & Industry Steve Rogers DG Enterprise &
European Commission Enterprise and Industry Communication on Tourism| July 12, 2010 | ‹#› Communication on Tourism Europe, the world’s no 1 tourist destination.
Aligning Policy Agendas The case of personalised care and cure for healthy and active ageing Setting the scene for the DG Regio and Flanders Smart Specialisation.
Revised Directive 2005/36/EC Nurses responsible for general care
Third EU Health Programme National Info day Athens, 21 April 2016 Courtesy of Irène Athanassoudis DG SANTE.
Richard Murrugarra – Centurion
INTERNATIONAL STATISTICAL INSTITUTE
Presidency Priorities of the Czech Republic in Better Regulation
MEP Interest Group on Brain, Mind and Pain
Support- IRDiRC Proposed Work Plan And Communication Strategy
ICPerMed – an International Consortium
International cooperation in Health
STANDARDISATION in the
Goal of Action Plan Implementation
The ERA.Net instrument Aims and benefits
Trust and Security Unit
SwafS Ethics and Research Integrity
Culture Statistics: policy needs
SwafS Ethics and Research Integrity
EUnetHTA Assembly May 2018.
Presentation transcript:

Research & Innovation International Rare Disease Consortium: Data Sharing Policy 3 rd International Traumatic Brain Injury Research Meeting Catherine BERENS Head of Sector Neuroscience Medical research and the challenge of ageing Unit DG Research & Innovation European Commission

Research & Innovation Goals of IRDiRC 200 new therapies for rare diseases by 2020 Means to diagnose most rare diseases by Images courtesy of FreeDigitalPhotos.net

Research & Innovation Basic principles of IRDiRC Co-operation at international level to stimulate, better coordinate & maximise output of rare disease research efforts around the world Teams up public and private organisations investing in rare diseases research Research funders with relevant programmes >$10 million US over a 5-year period can join & work together Each organisation funds research its own way Funded projects adhere to a common framework 3

Research & Innovation − 1 representative per funding body or group of funders − Representatives of umbrella organisations of patient advocacy groups − Chairs of the Scientific Committees Around 15 top-level experts with balanced representation of scientists, patients, industry, etc. Representatives of funded projects Executive Committee InterdisciplinaryTherapeuticsDiagnostics Scientific Committees Working Groups Ethics & governance Biobanks Registries & natural history Bio- informatics and data sharing Biomarkers Small molecules Repurposin g Bio- technology Regulatory OntologiesSequencing Model systems Genome/ phenome

Research & Innovation Policies Collaborative research: sharing resources, data and results among IRDiRC research projects; avoiding duplication; making publicly available Involve patients (or representatives) in all relevant research aspects International, national, regional and local legislation/regulation to be adhered to (data protection; ethics approvals) Generalized principles

Research & Innovation Guidelines Consider impact of research on patients as key: best ethical practices to ensure interest of individuals Disseminate and make available information about IRDiRC and IRDiRC projects Education, training and awareness of stakeholders to be encouraged by IRDiRC Generalized principles

Research & Innovation Policies Research projects should adhere to standards endorsed by IRDiRC Data producers acknowledge their responsibilities to (i) release data rapidly and (ii) publish initial analyses in a timely manner. IRDiRC members will encourage and facilitate rapid data release. Data sharing & standards Guidelines Data generated from research projects, incl. source data, to be deposited in appropriate open or controlled-access public databases

Research & Innovation Clinical Trials Regulation Responds to criticism of previous EU Clinical Trials Directive: Single submission portal for multinational trials Joint assessment by Member states' competent authorities Tacit-approval deadlines Reduced administrative burden (low-risk trials) Adopted on 16 April 2014 Applicable as from 6 months after the EU portal and database are functional (not earlier than May 2016) EU legislation revision (I)

Research & Innovation Personal Data Protection legislative framework Proposal of the European Commission: 25 January 2012: update and modernise the principles enshrined in the 1995 Data Protection Directive (digital age) build on the high level of data protection in place in Europe Positive vote of European Parliament: 12 March 2014 Awaiting position of Council Moving from a Directive to a Regulation: one continent = one law, with effective sanctions Level-playing field: operate on EU market = stick to EU law Right to be forgotten Simplification: "one-stop-shop" EU legislation revision (II)

Research & Innovation How does this link to InTBIR? IRDiRC policies and guidelines are broad Could be adapted to be fit for purpose Important aspects of Collaborative research Involvement of patients/representatives Respect legislation Conclusions

Research & Innovation Thank you!